Public, NASDAQ:OSIP
NASDAQ Global Select Market
OSI initiates Phase I study of lymphoma drug
Date: Wed, 16 Jul 2008 14:52:04 GMT
Tags:
OSI initiates Phase I study of lymphoma drug
Trading Markets (press release) - Jul 16, 2008
Trading Markets (press release) - Jul 16, 2008
Jul 16 , 2008 ( Datamonitor via COMTEX ) - - OSIP | Quote | Chart | News | PowerRating - - OSI Pharmaceuticals has initiated a Phase I clinical trial of OSI - 027 , an oral , potent and selective ...
OSI Pharma Commences early stage trial of OSI-027 in Patients with Advanced Solid Tumors
Date: Tue, 15 Jul 2008 18:18:59 GMT
Tags:
OSI Pharma Commences early stage trial of OSI-027 in Patients with Advanced Solid Tumors
RTT News - Jul 15, 2008
RTT News - Jul 15, 2008
( RTTNews ) - OSI Pharmaceuticals Inc . ( OSIP : News , Chart , Quote ) said Tuesday that it has initiated an early stage trial of OSI - 027 , an oral , potent and selective inhibitor of both ...
OSI Pharmaceuticals Begins Clinical Development Program for OSI-027 in Patients with Advanced Solid Tumors or Lymphoma
Date: Tue, 15 Jul 2008 11:38:40 GMT
Tags:
OSI Pharmaceuticals Begins Clinical Development Program for OSI-027 in Patients with Advanced Solid Tumors or Lymphoma
Business Wire (press release) - Jul 15, 2008
Business Wire (press release) - Jul 15, 2008
MELVILLE , NY - - ( BUSINESS WIRE ) - - OSI Pharmaceuticals , Inc . ( NASDAQ : OSIP ) announced today that it has initiated a Phase I clinical trial of OSI - 027 , an oral , potent and selective ...
OSI Pharmaceuticals to Announce Second Quarter Financial Results on July 23, 2008
Date: Wed, 09 Jul 2008 14:15:26 GMT
Tags:
OSI Pharmaceuticals to Announce Second Quarter Financial Results on July 23, 2008
Business Wire (press release) - Jul 9, 2008
Business Wire (press release) - Jul 9, 2008
MELVILLE , NY - - ( BUSINESS WIRE ) - - OSI Pharmaceuticals , Inc . ( Nasdaq : OSIP ) announced today that its second quarter 2008 financial results will be released on July 23 , 2008 , after ...
OSI Pharmaceuticals Inc declares conversion period for convertible senior notes
Date: Mon, 07 Jul 2008 09:51:53 GMT
Tags:
OSI Pharmaceuticals Inc declares conversion period for convertible senior notes
Trading Markets (press release) - Jul 7, 2008
Trading Markets (press release) - Jul 7, 2008
Jul 07 , 2008 ( M2 EQUITYBITES via COMTEX ) - - OSIP | Quote | Chart | News | PowerRating - - OSI Pharmaceuticals Inc ( Nasdaq : OSIP ) , a provider of high - quality and novel pharmaceutical ...
A Big Move From ViroPharma (at Motley Fool)
Date: Wed, 16 Jul 2008 19:40:45 Etc/GMT
Tags:
OSI PHARMACEUTICALS INC Files SEC form 8-K, Other Events (EDGAR Online)
Date: Tue, 15 Jul 2008 18:49:44 Etc/GMT
Tags:
Biotech Stocks: Genentech, J&J boost drug sector (at MarketWatch)
Date: Tue, 15 Jul 2008 14:12:00 Etc/GMT
Tags:
Drug stocks trend higher after sector bellwethers Genentech and Johnson & Johnson issue largely favorable second-quarter earnings reports and raise their 2008 financial forecasts.
OSI Pharmaceuticals Begins Clinical Development Program for OSI-027 in Patients with Advanced Solid Tumors or Lymphoma (Business Wire)
Date: Tue, 15 Jul 2008 11:30:00 Etc/GMT
Tags:
MELVILLE, N.Y.----OSI Pharmaceuticals, Inc. announced today that it has initiated a Phase I clinical trial of OSI-027, an oral, potent and selective inhibitor of both the TORC1 and TORC2 complexes that inhibits the kinase activity associated with mTOR .
Genentech reports 5% boost in second-quarter profit (at MarketWatch)
Date: Mon, 14 Jul 2008 22:08:00 Etc/GMT
Tags:
Genentech Inc. reported late Monday that its second-quarter profit rose 5%, thanks in part to double-digit sales growth for its cancer treatments Avastin, Rituxan and Tarceva.